NEW YORK (GenomeWeb News) – GATC Biotech has received certification from Illumina to provide their customers next-generation sequencing and other services using the Genome Analyzer IIx.

The German sequencing services firm has completed the Certified Service Provider Program (CSPro), which involves a two-stage process for testing sequencing data. Receiving the CSPro certification also gives the company preferential access to new Illumina technical developments, platforms, and upgrades, said GATC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.